Smoking and outcomes following personalized antiplatelet therapy in chronic coronary syndrome patients: A substudy from the randomized PATH-PCI trial.

Clin Cardiol · 2024 · PMC10933083 · PMID 38472152

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

showed a trendp = .052so close (0.05 < p ≤ 0.1)

Notably, it showed a trend for a lower rate of TVR in personalized group (0.2% vs. 1.4%, HR = 0.128, 95% CI, 0.016−1.020, p = .052).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.